相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
Amy L. Gillespie et al.
BMC PSYCHIATRY (2017)
Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population
Q. Xu et al.
PHARMACOGENOMICS JOURNAL (2016)
Neuroimaging biomarkers to predict treatment response in schizophrenia
P. Dazzan
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine
Danielle L. Taylor et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response
Eric Huang et al.
PHARMACOGENOMICS (2016)
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J. Lally et al.
PSYCHOLOGICAL MEDICINE (2016)
Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study
Nina Vanessa Kraguljac et al.
SCHIZOPHRENIA BULLETIN (2016)
The role of the ITIH3 rs2535629 variant in antipsychotic response
J. Brandl et al.
SCHIZOPHRENIA RESEARCH (2016)
An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation
Eilis Hannon et al.
GENOME BIOLOGY (2016)
Response to clozapine in a clinically identifiable subtype of schizophrenia
Nancy J. Butcher et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy
Maryam Ravan et al.
CLINICAL NEUROPHYSIOLOGY (2015)
Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia
Valerie M. Anderson et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment
Mohamed Ahmed et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes
Marina Mitjans et al.
PHARMACOGENETICS AND GENOMICS (2015)
Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia
Anil K. Malhotra
SCHIZOPHRENIA BULLETIN (2015)
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
Deepak K. Sarpal et al.
JAMA PSYCHIATRY (2015)
Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients
J. Frank et al.
MOLECULAR PSYCHIATRY (2015)
COMT and STH polymorphisms interaction on cognition in schizophrenia
Marta Bosia et al.
NEUROLOGICAL SCIENCES (2015)
Associations between brain morphology and outcome in schizophrenia in a general population sample
E. Jaaskelainen et al.
EUROPEAN PSYCHIATRY (2014)
Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia
Jennifer A. Hadley et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients
Matea Nikolac Perkovic et al.
PSYCHOPHARMACOLOGY (2014)
Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia
Vicente Molina et al.
SCHIZOPHRENIA RESEARCH (2014)
Effects of Clozapine on Heart Rate Dynamics and Their Relationship With Therapeutic Response in Treatment-Resistant Schizophrenia
Jong-Hoon Kim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
Oliver D. Howes et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Current status and future prospects for epigenetic psychopharmacology
Marco P. Boks et al.
EPIGENETICS (2012)
Association Study of 27 Annotated Genes for Clozapine Pharmacogenetics Validation of Preexisting Studies and Identification of a New Candidate Gene, ABCB1, for Treatment Response
Seung-Tae Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration
Rudi Hwang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
The Pharmacogenetics of Symptom Response to Antipsychotic Drugs
Gavin P. Reynolds
PSYCHIATRY INVESTIGATION (2012)
Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia
A. P. Rajkumar et al.
PSYCHOPHARMACOLOGY (2012)
Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: An event-related potential study
Ann-Christine Ehlis et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia
Takefumi Suzuki et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
J. L. McClay et al.
MOLECULAR PSYCHIATRY (2011)
Genome-wide association study identifies five new schizophrenia loci
Stephan Ripke et al.
NATURE GENETICS (2011)
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response
Rudi Hwang et al.
PHARMACOGENOMICS (2011)
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response
Tristram A. P. Lett et al.
SCHIZOPHRENIA RESEARCH (2011)
A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy
Ahmad Khodayari-Rostamabad et al.
CLINICAL NEUROPHYSIOLOGY (2010)
Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response
Renan P. Souza et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes
Renan P. Souza et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response
Renan P. Souza et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics
Fabiana B. Kohlrausch et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia
Renan P. Souza et al.
PHARMACOGENETICS AND GENOMICS (2010)
Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
R. Hwang et al.
PHARMACOGENOMICS JOURNAL (2010)
Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
Mingqing Xu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Lack of Association Between DRD3 Gene Polymorphism and Response to Clozapine in Turkish Schizoprenia Patients
I. Omer Barlas et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects
Renan P. Souza et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation
Lingjun Zuo et al.
PHARMACOGENETICS AND GENOMICS (2009)
The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response
Aygun Ertugrul et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia
Tomas Kasparek et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data
Chao-Cheng Lin et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia
Herbert Y. Meltzer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
G-protein gene 825C > T polymorphism is associated with response to clozapine in Brazilian schizophrenics
Fabiana B. Kohlrausch et al.
PHARMACOGENOMICS (2008)
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response
Renan P. Souza et al.
PSYCHOPHARMACOLOGY (2008)
Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response
Rudi Hwang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels
Aygun Ertugrul et al.
PSYCHIATRY RESEARCH (2007)
Family and case-control association study of the tumor necrosis factor-alpha (TNF-α) gene with schizophrenia and response to antipsychotic medication
Gwyneth Zai et al.
PSYCHOPHARMACOLOGY (2006)
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia
Shon W. Lewis et al.
SCHIZOPHRENIA BULLETIN (2006)
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment
R Hwang et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine
AL Zhao et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2005)
Suggestive association between the C825T polymorphism of the G-protein β3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia
DJ Müller et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia
T Sumiyoshi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations
R Hwang et al.
PSYCHOPHARMACOLOGY (2005)
Predictors and markers of clozapine response
C Chung et al.
PSYCHOPHARMACOLOGY (2005)
An association study of the neurotensin receptor gene with schizophrenia and clozapine response
P Huezo-Diaz et al.
SCHIZOPHRENIA RESEARCH (2004)
Monoamine oxidases: Certainties and uncertainties
KF Tipton et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex
AC Lahti et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
MOLECULAR PSYCHIATRY (2004)
Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia
V Molina et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2003)
An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients
CJ Hong et al.
NEUROSCIENCE LETTERS (2003)
The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes
C Arango et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Functional effects of antipsychotic drugs: Comparing clozapine with haloperidol
AC Lahti et al.
BIOLOGICAL PSYCHIATRY (2003)
No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine
SJ Tsai et al.
SCHIZOPHRENIA RESEARCH (2003)
Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study
NEM van Haren et al.
SCHIZOPHRENIA RESEARCH (2003)
D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine
SG Potkin et al.
MOLECULAR PSYCHIATRY (2003)
Predictors of clinical outcome in schizophrenic patients responding to clozapine
MC Mauri et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response
D Mancama et al.
NEUROSCIENCE LETTERS (2002)
Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response
B Gutiérrez et al.
SCHIZOPHRENIA RESEARCH (2002)
Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia
CJ Hong et al.
PSYCHIATRIC GENETICS (2001)
The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients
FE Scheepers et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients - A preliminary study
UG Kang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2001)
Association analysis of polymorphism in the promoter region of the α2a-adrenoceptor gene with schizophrenia and clozapine response
SJ Tsai et al.
SCHIZOPHRENIA RESEARCH (2001)
Prefrontal cortical sulcal widening associated with poor treatment response to clozapine
PE Konicki et al.
SCHIZOPHRENIA RESEARCH (2001)
Serotonin transporter polymorphisms:: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia
R Kaiser et al.
MOLECULAR PSYCHIATRY (2001)
Lack of association between the T→C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia
M Masellis et al.
SCHIZOPHRENIA RESEARCH (2001)
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients
M Dettling et al.
PSYCHOPHARMACOLOGY (2000)
EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia
V Knott et al.
CLINICAL ELECTROENCEPHALOGRAPHY (2000)
Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response
JT Birkett et al.
NEUROREPORT (2000)
Pharmacogenetic prediction of clozapine response
MJ Arranz et al.
LANCET (2000)
No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response
AA Bolonna et al.
NEUROSCIENCE LETTERS (2000)
Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response
SJ Tsai et al.
SCHIZOPHRENIA RESEARCH (2000)
Association study of apolipoprotein E epsilon 4 with clinical phenotype and clozapine response in schizophrenia
CJ Hong et al.
NEUROPSYCHOBIOLOGY (2000)
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics
E Spina et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
